Cargando…

Identifying Innate Resistance Hotspots for SARS-CoV-2 Antivirals Using In Silico Protein Techniques

The development and approval of antivirals against SARS-CoV-2 has further equipped clinicians with treatment strategies against the COVID-19 pandemic, reducing deaths post-infection. Extensive clinical use of antivirals, however, can impart additional selective pressure, leading to the emergence of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Portelli, Stephanie, Heaton, Ruby, Ascher, David B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531314/ https://www.ncbi.nlm.nih.gov/pubmed/37761839 http://dx.doi.org/10.3390/genes14091699

Ejemplares similares

SARS-CoV-2 infection and the antiviral innate immune response
por: Yang, Hui, et al.
Publicado: (2020)

Hotspot Mutations in SARS-CoV-2
por: Saha, Indrajit, et al.
Publicado: (2021)

In silico evidence of beauvericin antiviral activity against SARS-CoV-2
por: Al Khoury, Charbel, et al.
Publicado: (2022)

The molecular mechanism of SARS-CoV-2 evading host antiviral innate immunity
por: Gu, Wenjing, et al.
Publicado: (2022)

The Evolutionary Dance between Innate Host Antiviral Pathways and SARS-CoV-2
por: Aliyari, Saba R., et al.
Publicado: (2022)

In silico design of antiviral peptides targeting the spike protein of SARS-CoV-2
por: Ling, Rongsong, et al.
Publicado: (2020)

Author's overview: identifying SARS-CoV-2 antiviral compounds
por: Diffley, John F.X.
Publicado: (2021)

Identifying Hotspots in Binding of SARS-CoV-2 Spike Glycoprotein and Human ACE2
por: Mendis, Jenny, et al.
Publicado: (2021)

Phase Separation: The Robust Modulator of Innate Antiviral Signaling and SARS-CoV-2 Infection
por: Zheng, Yi, et al.
Publicado: (2023)

In silico evaluation of flavonoids as effective antiviral agents on the spike glycoprotein of SARS-CoV-2
por: Jain, Anisha S., et al.
Publicado: (2021)

SARS-CoV-2 seroprevalence in COVID-19 hotspots
por: Eckerle, Isabella, et al.
Publicado: (2020)

Allosteric Hotspots in the Main Protease of SARS-CoV-2
por: Strömich, Léonie, et al.
Publicado: (2022)

SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
por: Elshabrawy, Hatem A.
Publicado: (2020)

SARS-CoV-2 membrane glycoprotein M antagonizes the MAVS-mediated innate antiviral response
por: Fu, Yu-Zhi, et al.
Publicado: (2020)

Pre-infection antiviral innate immunity contributes to sex differences in SARS-CoV-2 infection
por: Sauerwald, Natalie, et al.
Publicado: (2022)

Potential antiviral properties of antiplatelet agents against SARS-CoV-2 infection: an in silico perspective
por: Abosheasha, Mohammed A., et al.
Publicado: (2021)

In silico identification of SARS-CoV-2 cell entry inhibitors from selected natural antivirals
por: Şimşek, Yusuf, et al.
Publicado: (2021)

In Silico Prediction and Selection of Target Sequences in the SARS-CoV-2 RNA Genome for an Antiviral Attack
por: Hussein, Mouraya, et al.
Publicado: (2022)

Antiviral Activity of Metabolites from Peruvian Plants against SARS-CoV-2: An In Silico Approach
por: Goyzueta-Mamani, Luis Daniel, et al.
Publicado: (2021)

In-silico screening and in-vitro assay show the antiviral effect of Indomethacin against SARS-CoV-2
por: Chakraborty, Rajkumar, et al.
Publicado: (2022)

Inhibition of SARS-CoV2 viral infection with natural antiviral plants constituents: An in-silico approach
por: Das, Kuntal, et al.
Publicado: (2023)

V483A: an emerging mutation hotspot of SARS-CoV-2
por: Ashwaq, Omar, et al.
Publicado: (2021)

Indels in SARS-CoV-2 occur at template-switching hotspots
por: Chrisman, Brianna Sierra, et al.
Publicado: (2021)

Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza
por: Abbott, Timothy R., et al.
Publicado: (2020)

SARS-CoV-2 Antiviral Therapy
por: Tao, Kaiming, et al.
Publicado: (2021)

Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods
por: Ginex, Tiziana, et al.
Publicado: (2021)

Antiviral Effect of Budesonide against SARS-CoV-2
por: Heinen, Natalie, et al.
Publicado: (2021)

Antiviral zinc oxide nanoparticles mediated by hesperidin and in silico comparison study between antiviral phenolics as anti-SARS-CoV-2
por: Attia, Gouda H., et al.
Publicado: (2021)

Phylogenetic analysis of 17271 Indian SARS-CoV-2 genomes to identify temporal and spatial hotspot mutations
por: Ghosh, Nimisha, et al.
Publicado: (2022)

SARS-CoV-2 Spike Antagonizes Innate Antiviral Immunity by Targeting Interferon Regulatory Factor 3
por: Freitas, Raul S., et al.
Publicado: (2022)

Combined in silico and in vitro approaches identified the antipsychotic drug lurasidone and the antiviral drug elbasvir as SARS-CoV2 and HCoV-OC43 inhibitors
por: Milani, Mario, et al.
Publicado: (2021)

Docking and in silico toxicity assessment of Arthrospira compounds as potential antiviral agents against SARS-CoV-2
por: Petit, Léna, et al.
Publicado: (2021)

In silico screening of antiviral compounds from Moringa oleifera for inhibition of SARS-CoV-2 main protease
por: Sivani, Bala Mohan, et al.
Publicado: (2021)

Antiviral Activity of Two Marine Carotenoids against SARS-CoV-2 Virus Entry In Silico and In Vitro
por: Yim, Sung-Kun, et al.
Publicado: (2021)

In Silico Binding of 2-Aminocyclobutanones to SARS-CoV-2 Nsp13 Helicase and Demonstration of Antiviral Activity
por: Mohammad, Thahani S. Habeeb, et al.
Publicado: (2023)

Author Correction: Exploring the structural distribution of genetic variation in SARS-CoV-2 with the COVID-3D online resource
por: Portelli, Stephanie, et al.
Publicado: (2021)

In-silico approach to designing effective antiviral drugs against SARS-CoV-2 and SARS-CoV-1 from reported phytochemicals: a quality improvement study
por: Tuz-Zohura, Fatema-, et al.
Publicado: (2023)

Innate Immunity Evasion Strategies of Highly Pathogenic Coronaviruses: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Li, Jin-Yan, et al.
Publicado: (2021)

Phytochemical Moieties From Indian Traditional Medicine for Targeting Dual Hotspots on SARS-CoV-2 Spike Protein: An Integrative in-silico Approach
por: Umashankar, V., et al.
Publicado: (2021)

Aminoglycosides and their potential as SARS-CoV-2 antivirals
por: Cimolai, Nevio
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_32oro39tm7k9rkqse08i1l56bj